Chinese Journal of Dermatology ›› 2020, Vol. 53 ›› Issue (7): 501-507.doi: 10.35541/cjd.20200603
• Expert Commentary • Previous Articles Next Articles
Li Li,Zhang Bin ,Wei Li ,Ma Lin
Received:
2020-06-15
Revised:
2020-06-18
Online:
2020-07-15
Published:
2020-07-06
Contact:
Ma Lin
E-mail:bch_maleen@aliyun.com
Li Li Zhang Bin Wei Li Ma Lin. Diagnosis and treatment of hemangiomas and vascular malformations: current status and prospect[J]. Chinese Journal of Dermatology, 2020, 53(7): 501-507.doi:10.35541/cjd.20200603
[1] | Munden A, Butschek R, Tom WL, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies[J]. Br J Dermatol, 2014,170(4):907⁃913. doi: 10.1111/bjd.12804. |
[2] | Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature[J]. Pediatr Dermatol, 2008,25(2):168⁃173. doi: 10.1111/j.1525⁃1470.2008. 00626.x. |
[3] | Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics[J]. Plast Reconstr Surg, 1982,69(3):412⁃422. doi: 10.1097/00006534⁃198203000⁃00002. |
[4] | Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations[J]. J Dermatol, 1997,24(11):701⁃710. doi: 10. 1111/j.1346⁃8138.1997.tb02522.x. |
[5] | Dasgupta R, Fishman SJ. ISSVA classification[J]. Semin Pediatr Surg, 2014,23(4):158⁃161. doi: 10.1053/j.sempedsurg. 2014.06.016. |
[6] | Léauté⁃Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy[J]. N Engl J Med, 2008,358(24):2649⁃2651. doi: 10.1056/NEJMc0708819. |
[7] | Barnés CM, Christison⁃Lagay EA, Folkman J. The placenta theory and the origin of infantile hemangioma[J]. Lymphat Res Biol, 2007,5(4):245⁃255. doi: 10.1089/lrb.2007.1018. |
[8] | Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex[J]. Arch Dermatol, 2002,138(12):1567⁃1576. doi: 10.1001/archderm.138.12.1567. |
[9] | Reimer A, Fliesser M, Hoeger PH. Anatomical patterns of infantile hemangioma (IH) of the extremities (IHE)[J]. J Am Acad Dermatol, 2016,75(3):556⁃563. doi: 10.1016/j.jaad.2016. 03.029. |
[10] | Yeh I, Bruckner AL, Sanchez R, et al. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy[J]. Pediatr Dermatol, 2011,28(3):267⁃275. doi: 10.1111/j.1525⁃1470.2011.01421.x. |
[11] | Metry D, Heyer G, Hess C, et al. Consensus statement on diagnostic criteria for PHACE syndrome[J]. Pediatrics, 2009,124(5):1447⁃1456. doi: 10.1542/peds.2009⁃0082. |
[12] | Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies[J]. J Pediatr, 2010,157(5):795⁃801.e1⁃7. doi: 10.1016/j.jpeds.2010.05.027. |
[13] | 中华医学会皮肤性病学分会儿童学组,中华医学会儿科学分会皮肤性病学组,中国医师协会皮肤科医师分会儿童皮肤病专业委员会,等. β受体阻滞剂治疗婴儿血管瘤中国专家共识[J].中华皮肤科杂志, 2020,53(7):493⁃500. doi: 10.35541/cjd.20200302. |
[14] | Nasseri E, Piram M, McCuaig CC, et al. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature[J]. J Am Acad Dermatol, 2014,70(1):75⁃79. doi: 10.1016/j.jaad.2013.09.018. |
[15] | Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution[J]. J Pediatr, 1996,128(3):329⁃335. doi: 10.1016/s0022⁃3476(96)70276⁃7. |
[16] | Enjolras O, Mulliken JB, Boon LM, et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly[J]. Plast Reconstr Surg, 2001,107(7):1647⁃1654. doi: 10.1097/0000 6534⁃200106000⁃00002. |
[17] | Roebuck D, Sebire N, Lehmann E, et al. Rapidly involuting congenital haemangioma (RICH) of the liver[J]. Pediatr Radiol, 2012,42(3):308⁃314. doi: 10.1007/s00247⁃011⁃2268⁃z. |
[18] | Ozcan UA. Rapidly involuting congenital hemangioma: a case of complete prenatal involution[J]. J Clin Ultrasound, 2010,38(2):85⁃88. doi: 10.1002/jcu.20647. |
[19] | Weitz NA, Lauren CT, Starc TJ, et al. Congenital cutaneous hemangioma causing cardiac failure: a case report and review of the literature[J]. Pediatr Dermatol, 2013,30(6):e180⁃e190. doi: 10.1111/j.1525⁃1470.2012.01875.x. |
[20] | Ji Y, Chen S, Yang K, et al. Kaposiform hemangioendothelioma: current knowledge and future perspectives[J]. Orphanet J Rare Dis, 2020,15(1):39. doi: 10.1186/s13023⁃020⁃1320⁃1. |
[21] | Putra J, Gupta A. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis[J]. Pathology, 2017,49(4):356⁃362. doi: 10.1016/j.pathol.2017.03. 001. |
[22] | Mahajan P, Margolin J, Iacobas I. Kasabach⁃Merritt phenomenon: classic presentation and management options[J]. Clin Med Insights Blood Disord, 2017,10:1179545X17699849. doi: 10.1177/1179545X17699849. |
[23] | Johnson AB, Richter GT. Vascular anomalies[J]. Clin Perinatol, 2018,45(4):737⁃749. doi: 10.1016/j.clp.2018.07.010. |
[24] | Hall GW. Kasabach⁃Merritt syndrome: pathogenesis and management[J]. Br J Haematol, 2001,112(4):851⁃862. doi: 10. 1046/j.1365⁃2141.2001.02453.x. |
[25] | O′Rafferty C, O′Regan GM, Irvine AD, et al. Recent advances in the pathobiology and management of Kasabach⁃Merritt phenomenon[J]. Br J Haematol, 2015,171(1):38⁃51. doi: 10. 1111/bjh.13557. |
[26] | Croteau SE, Liang MG, Kozakewich HP, et al. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach⁃Merritt phenomenon in 107 referrals[J]. J Pediatr, 2013,162(1):142⁃147. doi: 10.1016/j.jpeds.2012.06.044. |
[27] | Drolet BA, Trenor CC 3rd, Brandão LR, et al. Consensus⁃derived practice standards plan for complicated Kaposiform hemangioendothelioma[J]. J Pediatr, 2013,163(1):285⁃291. doi: 10.1016/j.jpeds.2013.03.080. |
[28] | Peng S, Yang K, Xu Z, et al. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma[J]. J Paediatr Child Health, 2019,55(9):1119⁃1124. doi: 10.1111/jpc.14370. |
[29] | Schmid I, Klenk AK, Sparber⁃Sauer M, et al. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options[J]. World J Pediatr, 2018,14(4):322⁃329. doi: 10.1007/s12519⁃018⁃0171⁃5. |
[30] | 中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形的诊断及治疗指南(2019版)[J]. 组织工程与重建外科杂志, 2019,15(5):277⁃317. doi: 10.3969/j.issn.1673⁃0364.2019.05.001. |
[31] | Shirley MD, Tang H, Gallione CJ, et al. Sturge⁃Weber syndrome and port⁃wine stains caused by somatic mutation in GNAQ[J]. N Engl J Med, 2013,368(21):1971⁃1979. doi: 10.1056/NEJMoa 1213507. |
[32] | Tatton⁃Brown K, Weksberg R. Molecular mechanisms of childhood overgrowth[J]. Am J Med Genet C Semin Med Genet, 2013,163C(2):71⁃75. doi: 10.1002/ajmg.c.31362. |
[33] | Rodriguez⁃Laguna L, Ibañez K, Gordo G, et al. CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype[J]. Genet Med, 2018,20(8):882⁃889. doi: 10.1038/gim.2017.200. |
[34] | Nguyen D, Turner JT, Olsen C, et al. Cutaneous manifestations of proteus syndrome: correlations with general clinical severity[J]. Arch Dermatol, 2004,140(8):947⁃953. doi: 10.1001/archderm.140.8.947. |
[35] | Wouters V, Limaye N, Uebelhoer M, et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper⁃phosphorylating effects[J]. Eur J Hum Genet, 2010,18(4):414⁃420. doi: 10.1038/ejhg. 2009.193. |
[36] | Limaye N, Kangas J, Mendola A, et al. Somatic activating PIK3CA mutations cause venous malformation[J]. Am J Hum Genet, 2015,97(6):914⁃921. doi: 10.1016/j.ajhg.2015.11.011. |
[37] | Özgönenel B, Martin A. Low⁃dose sirolimus controls recurrent iron deficiency in a patient with blue rubber bleb nevus syndrome[J]. Pediatr Blood Cancer, 2015,62(11):2054⁃2055. doi: 10.1002/pbc.25590. |
[38] | 张斌, 李丽, 尉莉, 等. 口服西罗莫司治疗儿童复杂性静脉畸形的效果和安全性: 一项单中心前瞻性研究[J]. 中华整形外科杂志, 2020,36(5):483⁃493. doi: 10.3760/cma.j.cn114453⁃20200315⁃00152. |
[39] | Zhang B, Li L, Zhang N, et al. Efficacy and safety of sirolimus in the treatment of blue rubber bleb naevus syndrome in paediatric patients[J]. Clin Exp Dermatol, 2020,45(1):79⁃85. doi: 10. 1111/ced.14003. |
[40] | Luks VL, Kamitaki N, Vivero MP, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA[J]. J Pediatr, 2015,166(4):1048⁃1054.e1⁃5. doi: 10.1016/j.jpeds.2014.12.069. |
[41] | Ivars M, Redondo P. Efficacy of topical sirolimus (rapamycin) for the treatment of microcystic lymphatic malformations[J]. JAMA Dermatol, 2017,153(1):103⁃105. doi: 10.1001/jamadermatol.2016.3697. |
[42] | Shoji MK, Shishido S, Freitag SK. The use of sirolimus for treatment of orbital lymphatic malformations: a systematic review[J]. Ophthalmic Plast Reconstr Surg, 2020,36(3):215⁃221. doi: 10.1097/IOP.0000000000001518. |
[43] | Burrows PE, Mulliken JB, Fishman SJ, et al. Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child[J]. J Craniofac Surg, 2009,20 Suppl 1:597⁃602. doi: 10.1097/SCS.0b013e3181927f1e. |
[44] | Lekwuttikarn R, Lim YH, Admani S, et al. Genotype⁃guided medical treatment of an arteriovenous malformation in a child[J]. JAMA Dermatol, 2019,155(2):256⁃257. doi: 10.1001/jamadermatol.2018.4653. |
[1] | Sun Xiaojie, Liu Yi. Anti-androgen drugs in the treatment of skin diseases [J]. Chinese Journal of Dermatology, 2023, 56(9): 882-885. |
[2] | Wang Yuqian, Qiao Jianjun, Fang Hong. Comparison of the latest Chinese and international guidelines/consensus on diagnosis and treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 885-888. |
[3] | Chen Xiaomin, Zhang Jingzhan, Ding Yuan, Kang Xiaojing. Metformin in the treatment of psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(8): 799-802. |
[4] | Yuan Xingang, Ni Sili, Zhang Jian, Luo Xiaoyan, Wang Hua. Improving diagnosis and treatment of melanocytic nevi in children: an urgent need [J]. Chinese Journal of Dermatology, 2023, 56(8): 782-786. |
[5] | Zhong Jiemin, Shao Lei, Liang Yimin, Huang Qiongxiao, Xia Manqi, Liu Yumei. Comparative study on efficacy and safety of single microneedle radiofrequency versus photodynamic therapy in the treatment of inflammatory lesions of moderate to severe facial acne vulgaris [J]. Chinese Journal of Dermatology, 2023, 56(8): 751-755. |
[6] | Song Zhiqiang, Chen Qiquan, Ge Lan. Insights into the progress in targeted therapy of atopic dermatitis from the perspective of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(8): 718-723. |
[7] | Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China (2023 edition) [J]. Chinese Journal of Dermatology, 2023, 56(7): 573-625. |
[8] | Li Yue, Wu Jinyan, Yuan Ruoyue, Yang Quyang, Zhao Xiansheng, Zhu Ningwen. Cell therapy for hereditary epidermolysis bullosa [J]. Chinese Journal of Dermatology, 2023, 56(7): 698-702. |
[9] | Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang. Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023)” based on the Delphi method [J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539. |
[10] | Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023) [J]. Chinese Journal of Dermatology, 2023, 56(6): 479-488. |
[11] | Chen Qiquan, Yang Xianjie, Wang Wenwen, Liang Gaopeng, Song Zhiqiang . Development and application of clinical assessment tools for cholinergic urticaria [J]. Chinese Journal of Dermatology, 2023, 56(6): 563-566. |
[12] | Mi Shuhong, Yu Yanqin, Hao Jinqi, Li Wei, Zhang Yang, Jia Ximei, Huang Yuxian, Sun Huaiyu, Shi Jihai. Analysis of imaging characteristics of papulopustular rosacea by high-frequency ultrasound combined with color Doppler flow imaging [J]. Chinese Journal of Dermatology, 2023, 56(6): 540-544. |
[13] | Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558. |
[14] | Wang Min, He Pingxiu, Cheng Lifang, Hong Kechun, Ai Yong. A case of meningothelial hamartoma of the scalp [J]. Chinese Journal of Dermatology, 2023, 56(5): 449-450. |
[15] | Ren Fenfen, Wang Peng, Zhang Jingzhan, Kang Xiaojing. Network pharmacology-based prediction of potential effective components of traditional Chinese medicine and their molecular mechanisms of action in the anti-angiogenic treatment of Kaposi′s sarcoma [J]. Chinese Journal of Dermatology, 2023, 56(5): 428-433. |
|